Serum Market Intelligence

Report Coverage

  • Category Opportunities & Risks

  • Cost Analysis and Expected Savings

  • Impact of COVID-19

Production Size

Global Production

704,000 Liters

North America Demand

CAGR: Apprx. 4–5 percent

Europe Demand

CAGR: Apprx. 5 percent

Table of contents

  1. Serum Executive Summary
  2. Executive Summary
  3. Supply Market Outlook
  4. Demand Market Outlook
  5. Beroe’s Recommendations for an ideal Category Strategy
  6. Category Opportunities & Risks
  7. Impact of COVID-19


  1. Serum COVID Section
  2. COVID Impact
  3. Sourcing Location Watch
  4. Supplier Watch
  5. Industry Watch


  1. Serum Market Overview
  2. Category Overview
  3. Market Overview
  4. Drivers and Constrains


  1. Serum Market Monitoring Insights
  2. Cost Structure Analysis
  3. Commodity Price Forecast
  4. Cost Analysis and Expected Savings


  1. Serum Market Trends
  2. Adoption Trends
  3. Geographical Origin and International Trade


  1. Serum Supplier Section
  2. Key Global Suppliers
  3. Supplier Profile
  4. Supplier SWOT
  5. Porter’s Five Forces Analysis


Want a more detailed personalised report?

Global Market Outlook on Serum 

  • Supply market for FBS is split across the US, Australia, Brazil, etc. The US contributes to the highest market share, which is greater than Australia and New Zealand

  • Dual sourcing of FBS is usually followed by major pharmaceutical companies for commercial manufacturing and R&D applications

  • Suppliers are evaluated for long-term supply assurance and traceability of serum

  • Usage of South American origin FBS has increased, particularly in the research community

Impact of COVID-19 on FBS 

  • FBS supply and pricing are dependent on several factors, such as environmental, geopolitical, etc. Hence, the supply continuity and price stability may be inconsistent to an extent

  • Scientists have spent several years in research, trying to find an alternative to FBS, but there is no solid alternative till date

Serum Market Overview 

  • Volume of FBS produced globally in 2020 is estimated to be around 704,000 L. The US, Australia, and Brazil are some of the major regions for FBS production.

  • The global FBS market is projected to grow at a rate of 4–5percent for the next five years and reach a total volume of nearly 899,000 L by 2025

  • New Zealand and Australia, having the lowest risk of BSE and TSE, are the most preferred locations for sourcing FBS

  • Increasing demand for FBS, coupled with slow growth in raw material fetal bovine blood (FBB), is one of the key challenges in the market

  • Although there is a shift toward artificial serum, there are certain applications for animal-based serum (especially, FBS), which cannot be overseen

Industry Drivers and Constraints


  • Demand for FBS has been driven by the rapid growth in the biopharmaceutical industry. Cell culture media has been supplemented by FBS for many decades now

  • Demand from new regions, like South Korea and other developing countries, is expected to fuel the demand for FBS

  • FBS sourced from New Zealand and Australia are always preferred over any other serum, since they are free from any risk and assumed to offer better results


  • Due to the certain scientific, ethical and supply challenges, researchers have been forced to identify an alternative for FBS

  • Supply of FBB is finite and it often affected by factors, like weather pattern, dairy market, cattle cycles, and beef demand•Issues in traceability with the supply chain of FBS is a crucial factor that affects market growth


SerumMarket Frequently Asked Questions

  1. How has the global serum market been performing?
  2. The worldwide serum supply in 2020 was around 704,000 L. As per Beroe’s category intelligence report, the global serum market will grow at 4-5% CAGR over the next five years, reaching nearly 899,000 L total volume.
  1. What factors are favoring the global serum market growth?
  2. Rapid growth in the biopharmaceutical industry has been the primary driver for the global serum market. The fetal bovine serum (FBS) has been supplementing cell culture media for several decades. Furthermore, increasing demand from emerging regions, such as South Korea and other developing nations, will likely offer another leg of growth.
  1. Which regions are highly preferred for sourcing the FBS?
  2. While the US holds a significant revenue share in the global serum market, players prefer Australia and New Zealand for sourcing FBS owing to the lowest risk of transmissible spongiform encephalopathy (TSE) and bovine spongiform encephalopathy (BSE).
  1. What challenges are players in the global serum market facing?
  2. Specific ethical, scientific, and supply challenges have compelled researchers to look for a substitute for FBS. Moreover, the supply of FBS is limited and is subject to various factors including, cattle cycles, beef demand, and weather patterns. Furthermore, issues with the supply chain monitoring of FBS are impacting manufacturers’ bottom lines.
  1. Is there any threat of substitutes in the global serum market?
  2. While there is a shift towards artificial serum, animal-based serums, especially FBS, find use in specific applications. Further, think tanks have dedicated several years to research in order to discover a substitute to FBS; however, they have yet to find a solid alternative.
  1. Which regions are the goldmines of opportunities in the global serum market?
  2. The US, Brazil, and Australia are the major serum producers worldwide. While the North American serum market is growing at a 4-5% CAGR, the market size in Europe is expanding at around 5% CAGR.

Complimentary 12-month access to Beroe LiVE

Any more questions?

Get in touch with us quickly and easily.


LiVE Event: Category Management For Procurement Professionals